Jeisys Medical Inc
KOSDAQ:287410
Jeisys Medical Inc
Total Equity
Jeisys Medical Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Total Equity
₩111.4B
|
CAGR 3-Years
60%
|
CAGR 5-Years
71%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Total Equity
₩320.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Total Equity
₩519.7B
|
CAGR 3-Years
37%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Total Equity
₩126.8B
|
CAGR 3-Years
129%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Total Equity
₩88.8B
|
CAGR 3-Years
50%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Total Equity
₩21.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jeisys Medical Inc
Glance View
Jeisys Medical, Inc. manufactures and develops products used by plastic surgeons, dermatologist, physicians and health professionals. The company is headquartered in Seoul, Seoul. The company went IPO on 2018-05-08. The firm manufactures and sells skin care medical devices such as ULTRAcel Q+, POTENZA, and other products. In addition, the Company also provides consumables such as cartridges and tips.
See Also
What is Jeisys Medical Inc's Total Equity?
Total Equity
111.4B
KRW
Based on the financial report for Jun 30, 2024, Jeisys Medical Inc's Total Equity amounts to 111.4B KRW.
What is Jeisys Medical Inc's Total Equity growth rate?
Total Equity CAGR 5Y
71%
Over the last year, the Total Equity growth was 31%. The average annual Total Equity growth rates for Jeisys Medical Inc have been 60% over the past three years , 71% over the past five years .
